Back

Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Primary Results.

27 August 2017 (16:05 - 16:25)
Organised by:
Congress Presentation Part of: Meet the Trialists - COMPASS Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor John William Eikelboom

McMaster University, Hamilton (Canada)

Access the full session

Session thumbnail
Meet the Trialists - COMPASS

The Event

Event poster

ESC Congress 2017

27 August 2017 16:05 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial
30 August 2020
thumbnail
ESC TV Today
Episode 4: Heart disease in dialysis patients - Substance abuse and heart disease
7 November 2024
thumbnail
Congress Presentation
Comparative effectiveness and safety of apixaban and low-molecular weight heparin among patients with venous thromboembolism and active cancer in an extended treatment setting
28 August 2023
thumbnail
Congress Presentation
Comparative efficacy and safety of antithrombotic regimens following left atrial appendage occlusion therapy in atrial fibrillation patients: a comprehensive Bayesian network meta-analysis
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources